Felix Drost
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Felix Drost has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin Schubert
Institute for Computational Biology, Helmholtz Zentrum München
12 shared publications - Kilian Schober
Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen und Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany
7 shared publications - Dirk H. Busch
Institute for Medical Microbiology, Immunology and Hygiene, School of Medicine and Health, Technical University of Munich, Munich, Germany
4 shared publications - Katharina Kocher
Mikrobiologisches Institut–Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
4 shared publications Bernd Spriewald
3 shared publications- Fabian Joachim Theis
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
3 shared publications
Latest Publications
- Open Access
DextraDemixer enables accurate identification of antigen-specific T cells from pMHC multimer experiments
Antigen specificity of T cells defines the adaptive immune response, yet the vast majority of known T cell receptors (TCRs) lack annotated antigen targets. Single-cell peptide-MHC (pMHC) multimer assays offer a scalable approach to map TCR-antigen interactions. Still, their utility is limited by pervasive non-specific binding and severe overlap between signal and noise, which confound the accurate identification of antigen-specific cells. To address these limitations, we present DextraDemixer, a Bayesian hierarchical mixture model that disentangles antigen-specific T cells from background noise in pMHC multimer data. The model integrates information from negative controls and clonotype structure while providing calibrated uncertainty estimates for classification. We further introduce a dynamic thresholding scheme that enables credible interval-bounded control of the false discovery rate. Extensive benchmarking on simulated datasets and antigen-specific spike-in experiments demonstrated the model's robustness and improved accuracy over established methods. In a longitudinal SARS-CoV-2 vaccine study, DextraDemixer identified antigen-specific TCRs characterized by high sequence similarity, elevated antigen-specificity prediction scores, and strong clonal purity. Annotations showed high concordance with external validation data and supported the identification of antigen-specific motifs. Overall, DextraDemixer provides a principled probabilistic framework for reliable identification of antigen-specific TCRs from single-cell pMHC-multimer assays.
Open AccessDextraDemixer enables accurate identification of antigen-specific T cells from pMHC multimer experiments
Antigen specificity of T cells defines the adaptive immune response, yet the vast majority of known T cell receptors (TCRs) lack annotated antigen targets. Single-cell peptide-MHC (pMHC) multimer assays offer a scalable approach to map TCR-antigen interactions. Still, their utility is limited by pervasive non-specific binding and severe overlap between signal and noise, which confound the accurate identification of antigen-specific cells. To address these limitations, we present DextraDemixer, a Bayesian hierarchical mixture model that disentangles antigen-specific T cells from background noise in pMHC multimer data. The model integrates information from negative controls and clonotype structure while providing calibrated uncertainty estimates for classification. We further introduce a dynamic thresholding scheme that enables credible interval-bounded control of the false discovery rate. Extensive benchmarking on simulated datasets and antigen-specific spike-in experiments demonstrated the model's robustness and improved accuracy over established methods. In a longitudinal SARS-CoV-2 vaccine study, DextraDemixer identified antigen-specific TCRs characterized by high sequence similarity, elevated antigen-specificity prediction scores, and strong clonal purity. Annotations showed high concordance with external validation data and supported the identification of antigen-specific motifs. Overall, DextraDemixer provides a principled probabilistic framework for reliable identification of antigen-specific TCRs from single-cell pMHC-multimer assays.
- Open Access
Antigen-reactive CD4+ T cells after SARS-CoV-2 vaccination show divergent phenotypic states with or without restimulation bias
Understanding antigen reactivity is crucial for characterizing CD4+ T helper (Th) cell fate, yet conventional peptide restimulation assays introduce phenotypic bias by activating cells ex vivo. However, by performing single-cell RNA and T cell receptor (TCR) sequencing on both antigen-stimulated and unstimulated samples, clonotypes can be tracked across conditions to identify antigen-reactive CD4+ T cells and simultaneously be assessed for their phenotypes in the unperturbed state. Using this reverse phenotyping strategy, complemented by DNA-barcoded peptide-HLA (pHLA) class II multimers, we here tracked SARS-CoV-2 spike-reactive CD4+ T cells longitudinally after repeated mRNA vaccination. Without stimulation, reactive clones showed more Th-neutral features and less of an activated Th1-like state than would be assessed after antigen restimulation. Furthermore, transgenic TCR re-expression guided separation of antigen-specific from bystander-activated clones. These results uncover unbiased phenotypes of antigen-reactive CD4+ T cells and highlight that cell state classification can differ fundamentally when judged by phenotype versus function.
Open AccessAntigen-reactive CD4+ T cells after SARS-CoV-2 vaccination show divergent phenotypic states with or without restimulation bias
Understanding antigen reactivity is crucial for characterizing CD4+ T helper (Th) cell fate, yet conventional peptide restimulation assays introduce phenotypic bias by activating cells ex vivo. However, by performing single-cell RNA and T cell receptor (TCR) sequencing on both antigen-stimulated and unstimulated samples, clonotypes can be tracked across conditions to identify antigen-reactive CD4+ T cells and simultaneously be assessed for their phenotypes in the unperturbed state. Using this reverse phenotyping strategy, complemented by DNA-barcoded peptide-HLA (pHLA) class II multimers, we here tracked SARS-CoV-2 spike-reactive CD4+ T cells longitudinally after repeated mRNA vaccination. Without stimulation, reactive clones showed more Th-neutral features and less of an activated Th1-like state than would be assessed after antigen restimulation. Furthermore, transgenic TCR re-expression guided separation of antigen-specific from bystander-activated clones. These results uncover unbiased phenotypes of antigen-reactive CD4+ T cells and highlight that cell state classification can differ fundamentally when judged by phenotype versus function.
- Open Access
Antigen receptor competition in CAR-TCR cells changes cytotoxicity outcomes upon spatial antigen separation
Chimeric antigen receptor T cells (CAR-T) are effective against cancer and autoimmunity, but the role of the endogenous T-cell receptor (TCR) remains unclear. Using TCRs as molecular barcodes, we traced anti-CD19 CAR-T clonotypes before and after infusion in patients with B-cell malignancies using single-cell sequencing. A cytotoxic phenotype, but not transcriptional responsiveness to tumor cells, correlated with CAR-T detection in vivo . To assess functional TCR contributions to CAR-T activity, we combined CAR transduction with orthotopic TCR replacement. Strong TCR signaling enhanced activation, but impaired CAR-mediated cytotoxicity when TCR and CAR antigens were presented by different target cells. Confocal imaging revealed preferential recruitment of cytolytic granules to the TCR synapse in cells simultaneously forming distinct CAR and TCR synapses. Thus, spatial antigen separation shapes receptor competition in CAR-TCR cells. Our findings have implications for therapeutic CAR-T design using defined TCRs to enhance cellular persistence or counteract tumor heterogeneity.
Open AccessAntigen receptor competition in CAR-TCR cells changes cytotoxicity outcomes upon spatial antigen separation
Chimeric antigen receptor T cells (CAR-T) are effective against cancer and autoimmunity, but the role of the endogenous T-cell receptor (TCR) remains unclear. Using TCRs as molecular barcodes, we traced anti-CD19 CAR-T clonotypes before and after infusion in patients with B-cell malignancies using single-cell sequencing. A cytotoxic phenotype, but not transcriptional responsiveness to tumor cells, correlated with CAR-T detection in vivo . To assess functional TCR contributions to CAR-T activity, we combined CAR transduction with orthotopic TCR replacement. Strong TCR signaling enhanced activation, but impaired CAR-mediated cytotoxicity when TCR and CAR antigens were presented by different target cells. Confocal imaging revealed preferential recruitment of cytolytic granules to the TCR synapse in cells simultaneously forming distinct CAR and TCR synapses. Thus, spatial antigen separation shapes receptor competition in CAR-TCR cells. Our findings have implications for therapeutic CAR-T design using defined TCRs to enhance cellular persistence or counteract tumor heterogeneity.
- 3 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (112) , eadu6730
Vaccination-induced T cell responses maintain polyclonality with high antigen receptor avidity
Clonal expansion is a hallmark of adaptive immunity and has been challenging to investigate in humans in a standardized manner compared with animal models. We studied a cohort of 29 healthy individuals who received three mRNA vaccinations against SARS-CoV-2 before a breakthrough infection. We characterized the magnitude, phenotype, and clonal composition of CD8 T cell responses against 16 epitope specificities by ELISpot; flow cytometry; and single-cell RNA, protein, and T cell receptor (TCR) sequencing. One hundred six TCRs from five epitope-specific repertoires were reexpressed and tested for peptide sensitivity. Whereas vaccination-recruited T cell repertoires were enriched for high-avidity TCRs, differential clonal expansion was not linked to fine avidity differences. Instead, maintenance of polyclonality ensured robustness in counteracting viral mutational escape through altered epitopes. Deciphering the functionality of human antigen-specific T cell repertoires instructs our understanding of human T cell biology and may guide the development of vaccines and other immunotherapies.
- 3 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (112) , eadu6730
Vaccination-induced T cell responses maintain polyclonality with high antigen receptor avidity
Clonal expansion is a hallmark of adaptive immunity and has been challenging to investigate in humans in a standardized manner compared with animal models. We studied a cohort of 29 healthy individuals who received three mRNA vaccinations against SARS-CoV-2 before a breakthrough infection. We characterized the magnitude, phenotype, and clonal composition of CD8 T cell responses against 16 epitope specificities by ELISpot; flow cytometry; and single-cell RNA, protein, and T cell receptor (TCR) sequencing. One hundred six TCRs from five epitope-specific repertoires were reexpressed and tested for peptide sensitivity. Whereas vaccination-recruited T cell repertoires were enriched for high-avidity TCRs, differential clonal expansion was not linked to fine avidity differences. Instead, maintenance of polyclonality ensured robustness in counteracting viral mutational escape through altered epitopes. Deciphering the functionality of human antigen-specific T cell repertoires instructs our understanding of human T cell biology and may guide the development of vaccines and other immunotherapies.
- Open Access
- 7 July 2025
- Published by Elsevier in Cell Genomics
- Vol. 5 (8) , 100946
Benchmarking of T cell receptor-epitope predictors with ePytope-TCR
- 7 July 2025
- Published by Elsevier in Cell Genomics
- Vol. 5 (8) , 100946
Open AccessBenchmarking of T cell receptor-epitope predictors with ePytope-TCR
- Open Access
Benchmarking of T-Cell Receptor - Epitope Predictors with ePytope-TCR
Understanding the recognition of disease-derived epitopes through T-cell receptors (TCRs) has the potential to serve as a stepping stone for the development of efficient immunotherapies and vaccines. While a plethora of sequence-based prediction methods for TCR-epitope binding exists, their available pre-trained models have not been comparatively evaluated on standardized datasets and evaluation settings. Furthermore, technical problems such as non-standardized input and output formats of these prediction tools hinder interoperability and broad usage in applied research. To alleviate these shortcomings, we introduce ePytope-TCR, an extension of the vaccine design and immuno-prediction framework ePytope. We integrated 18 TCR-epitope prediction methods into this common framework offering interoperable interfaces with standard TCR repertoire data formats. We showcase the applicability of ePytope-TCR by evaluating the performance of the prediction methods on two challenging datasets for annotating single-cell repertoires and predicting TCR cross-reactivity towards mutated epitopes. While novel predictors successfully predicted binding to frequently observed epitopes, all methods failed for less observed epitopes. Further, we detected a strong bias in the prediction scores between different epitope classes. We envision this benchmark to guide researchers in their choice of a predictor for a given setting. Further, we aspire to accelerate the development of novel prediction models by allowing fast benchmarking against existing approaches through common interfaces and defining standardized evaluation settings.
Open AccessBenchmarking of T-Cell Receptor - Epitope Predictors with ePytope-TCR
Understanding the recognition of disease-derived epitopes through T-cell receptors (TCRs) has the potential to serve as a stepping stone for the development of efficient immunotherapies and vaccines. While a plethora of sequence-based prediction methods for TCR-epitope binding exists, their available pre-trained models have not been comparatively evaluated on standardized datasets and evaluation settings. Furthermore, technical problems such as non-standardized input and output formats of these prediction tools hinder interoperability and broad usage in applied research. To alleviate these shortcomings, we introduce ePytope-TCR, an extension of the vaccine design and immuno-prediction framework ePytope. We integrated 18 TCR-epitope prediction methods into this common framework offering interoperable interfaces with standard TCR repertoire data formats. We showcase the applicability of ePytope-TCR by evaluating the performance of the prediction methods on two challenging datasets for annotating single-cell repertoires and predicting TCR cross-reactivity towards mutated epitopes. While novel predictors successfully predicted binding to frequently observed epitopes, all methods failed for less observed epitopes. Further, we detected a strong bias in the prediction scores between different epitope classes. We envision this benchmark to guide researchers in their choice of a predictor for a given setting. Further, we aspire to accelerate the development of novel prediction models by allowing fast benchmarking against existing approaches through common interfaces and defining standardized evaluation settings.
- Open Access
Quality of vaccination-induced T cell responses is conveyed by polyclonality and high, but not maximum, antigen receptor avidity
While the quantity of vaccination-induced T cells represents a routine immunogenicity parameter, the quality of such responses is poorly understood. We here report on a clinical cohort of 29 human healthy individuals who received three mRNA vaccinations against SARS-CoV-2 before any breakthrough infection. We characterized the magnitude, phenotype and clonal composition of CD8 T cell responses against 16 epitope specificities by ELISpot, flow cytometry as well as single-cell RNA, TCR and surface protein sequencing. To test the functionality of identified clonotypes, 106 T cell receptors (TCR) from five epitope-specific repertoires were re-expressed and tested for peptide sensitivity. While recruited repertoires were overall enriched for high-avidity TCRs, differential clonal expansion was not linked to fine avidity differences. Instead, maintenance of polyclonality ensured robustness in counteracting mutational escape of epitopes. Our findings on the induction and maintenance of high-functionality polyclonal T cell repertoires shed light on T cell quality as a neglected criterion in the assessment of vaccine immunogenicity.
Open AccessQuality of vaccination-induced T cell responses is conveyed by polyclonality and high, but not maximum, antigen receptor avidity
While the quantity of vaccination-induced T cells represents a routine immunogenicity parameter, the quality of such responses is poorly understood. We here report on a clinical cohort of 29 human healthy individuals who received three mRNA vaccinations against SARS-CoV-2 before any breakthrough infection. We characterized the magnitude, phenotype and clonal composition of CD8 T cell responses against 16 epitope specificities by ELISpot, flow cytometry as well as single-cell RNA, TCR and surface protein sequencing. To test the functionality of identified clonotypes, 106 T cell receptors (TCR) from five epitope-specific repertoires were re-expressed and tested for peptide sensitivity. While recruited repertoires were overall enriched for high-avidity TCRs, differential clonal expansion was not linked to fine avidity differences. Instead, maintenance of polyclonality ensured robustness in counteracting mutational escape of epitopes. Our findings on the induction and maintenance of high-functionality polyclonal T cell repertoires shed light on T cell quality as a neglected criterion in the assessment of vaccine immunogenicity.
- Open Access
- 15 August 2024
- Published by Elsevier in Cell Genomics
- Vol. 4 (9) , 100634
Predicting T cell receptor functionality against mutant epitopes
- 15 August 2024
- Published by Elsevier in Cell Genomics
- Vol. 4 (9) , 100634
Open AccessPredicting T cell receptor functionality against mutant epitopes
- Open Access
- 3 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Multi-modal generative modeling for joint analysis of single-cell T cell receptor and gene expression data
Recent advances in single-cell immune profiling have enabled the simultaneous measurement of transcriptome and T cell receptor (TCR) sequences, offering great potential for studying immune responses at the cellular level. However, integrating these diverse modalities across datasets is challenging due to their unique data characteristics and technical variations. Here, to address this, we develop the multimodal generative model mvTCR to fuse modality-specific information across transcriptome and TCR into a shared representation. Our analysis demonstrates the added value of multimodal over unimodal approaches to capture antigen specificity. Notably, we use mvTCR to distinguish T cell subpopulations binding to SARS-CoV-2 antigens from bystander cells. Furthermore, when combined with reference mapping approaches, mvTCR can map newly generated datasets to extensive T cell references, facilitating knowledge transfer. In summary, we envision mvTCR to enable a scalable analysis of multimodal immune profiling data and advance our understanding of immune responses.
- 3 July 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Open AccessMulti-modal generative modeling for joint analysis of single-cell T cell receptor and gene expression data
Recent advances in single-cell immune profiling have enabled the simultaneous measurement of transcriptome and T cell receptor (TCR) sequences, offering great potential for studying immune responses at the cellular level. However, integrating these diverse modalities across datasets is challenging due to their unique data characteristics and technical variations. Here, to address this, we develop the multimodal generative model mvTCR to fuse modality-specific information across transcriptome and TCR into a shared representation. Our analysis demonstrates the added value of multimodal over unimodal approaches to capture antigen specificity. Notably, we use mvTCR to distinguish T cell subpopulations binding to SARS-CoV-2 antigens from bystander cells. Furthermore, when combined with reference mapping approaches, mvTCR can map newly generated datasets to extensive T cell references, facilitating knowledge transfer. In summary, we envision mvTCR to enable a scalable analysis of multimodal immune profiling data and advance our understanding of immune responses.
- Open Access
Predicting T Cell Receptor Functionality against Mutant Epitopes
Cancer cells or pathogens can escape recognition by T cell receptors (TCRs) through mutations of immunogenic epitopes. TCR cross-reactivity, i.e., recognition of multiple epitopes with sequence similarities, can be a factor to counteract such mutational escape. However, cross-reactivity of cell-based immunotherapies may also cause severe side effects when self-antigens are targeted. Therefore, the ability to predict the effect of mutations in the epitope sequence on T cell functionality in silico would greatly benefit the safety and effectiveness of newly-developed immunotherapies and vaccines. We here present “Predicting T cell Epitope-specific Activation against Mutant versions” (P-TEAM), a Random Forest-based model which predicts the effect of point mutations of an epitope on T cell functionality. We first trained and tested P-TEAM on a comprehensive dataset of 36 unique murine TCRs in response to systematic single-amino acid mutations of their target epitope (representing 5.472 unique TCR-epitope interactions). The model was able to classify T cell reactivities, corresponding to in vivo recruitment of T cells, and quantitatively predict T cell functionalities for unobserved single-point mutated altered peptide ligands (APLs), or even unseen TCRs, with consistently high performance. Further, we present an active learning framework to guide experimental design for assessing TCR functionality against novel epitopes, minimizing primary data acquisition costs. Finally, we applied P-TEAM to a novel dataset of 7 human TCRs reactive to the tumor neoantigen VPSVWRSSL. We observed a similarly robust performance for these human TCRs as for the murine TCRs recognizing SIINFEKL, thus providing evidence that our approach is applicable to therapeutically relevant TCRs as well as across species. Overall, P-TEAM provides an effective computational tool to study T cell responses against mutated epitopes.
Open AccessPredicting T Cell Receptor Functionality against Mutant Epitopes
Cancer cells or pathogens can escape recognition by T cell receptors (TCRs) through mutations of immunogenic epitopes. TCR cross-reactivity, i.e., recognition of multiple epitopes with sequence similarities, can be a factor to counteract such mutational escape. However, cross-reactivity of cell-based immunotherapies may also cause severe side effects when self-antigens are targeted. Therefore, the ability to predict the effect of mutations in the epitope sequence on T cell functionality in silico would greatly benefit the safety and effectiveness of newly-developed immunotherapies and vaccines. We here present “Predicting T cell Epitope-specific Activation against Mutant versions” (P-TEAM), a Random Forest-based model which predicts the effect of point mutations of an epitope on T cell functionality. We first trained and tested P-TEAM on a comprehensive dataset of 36 unique murine TCRs in response to systematic single-amino acid mutations of their target epitope (representing 5.472 unique TCR-epitope interactions). The model was able to classify T cell reactivities, corresponding to in vivo recruitment of T cells, and quantitatively predict T cell functionalities for unobserved single-point mutated altered peptide ligands (APLs), or even unseen TCRs, with consistently high performance. Further, we present an active learning framework to guide experimental design for assessing TCR functionality against novel epitopes, minimizing primary data acquisition costs. Finally, we applied P-TEAM to a novel dataset of 7 human TCRs reactive to the tumor neoantigen VPSVWRSSL. We observed a similarly robust performance for these human TCRs as for the murine TCRs recognizing SIINFEKL, thus providing evidence that our approach is applicable to therapeutically relevant TCRs as well as across species. Overall, P-TEAM provides an effective computational tool to study T cell responses against mutated epitopes.